Literature DB >> 14657786

Behavioral quantitation is more sensitive than cognitive testing in frontotemporal dementia.

Andrew Kertesz1, Wilda Davidson, Patricia McCabe, David Munoz.   

Abstract

OBJECTIVE: To compare behavioral and cognitive testing in the clinical diagnosis of frontotemporal dementia (FTD).
METHODS: A clinically defined cohort of FTD (n = 52) is compared with 52 Alzheimer disease (AD) patients on a Frontal Behavioral Inventory (FBI) and cognitive tests (e.g., Mini-Mental State Examination, Mattis Dementia Rating Scale, Western Aphasia Battery, Wechsler Intelligence Scale, Wechsler Memory Scale). Fourteen patients with FTD had autopsy confirmation, and their tests are also compared with the rest of the FTD population.
RESULTS: The FTD and AD groups were matched in sex, duration, and severity of dementia. The total scores on the FBI showed the largest difference. Mini-Mental State Examination and Mattis Dementia Rating Scale total scores did not discriminate between the two groups. Memory subscores were lower in the AD group, and conceptualization and language-related scores were worse in the FTD group. Milder and earlier affected patients, who could carry on a large battery of neuropsychological tests, were much better distinguished by the FBI scores on discriminant function analysis. In contrast to 78% by the cognitive tests, 98% of the FTD and AD patients were differentiated by the FBI.
CONCLUSIONS: Although memory scores were lower in AD and language scores in the FTD population, many of the cognitive tests do not distinguish between FTD and AD. On the other hand, a behavioral inventory is a useful adjunct in the diagnosis of FTD. Postmortem validation was carried out in a sizeable subset of the population, showing similar behavioral and cognitive data.

Entities:  

Mesh:

Year:  2003        PMID: 14657786     DOI: 10.1097/00002093-200310000-00005

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  20 in total

1.  CSF metabolites in the differential diagnosis of Alzheimer's disease from frontal variant of frontotemporal dementia.

Authors:  Francesca de Rino; Filippo Martinelli-Boneschi; Francesca Caso; Marta Zuffi; Matteo Zabeo; Gabriella Passerini; Giancarlo Comi; Giuseppe Magnani; Massimo Franceschi
Journal:  Neurol Sci       Date:  2011-11-29       Impact factor: 3.307

2.  MMSE scores decline at a greater rate in frontotemporal degeneration than in AD.

Authors:  Tiffany W Chow; Linda S Hynan; Anne M Lipton
Journal:  Dement Geriatr Cogn Disord       Date:  2006-08-07       Impact factor: 2.959

Review 3.  Neuropsychological differences between frontotemporal dementia and Alzheimer's disease: a review.

Authors:  Michal Harciarek; Krzysztof Jodzio
Journal:  Neuropsychol Rev       Date:  2005-09       Impact factor: 7.444

4.  Organizing a Series of Education and Support Conferences for Caregivers of Individuals With Frontotemporal Dementia and Primary Progressive Aphasia.

Authors:  Sarah Banks; Emily Rogalski; Jennifer Medina; Andrea Skoglund; Darby Morhardt
Journal:  Alzheimers Care Q       Date:  2006-10-01

Review 5.  Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic review.

Authors:  A D Hutchinson; J L Mathias
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-19       Impact factor: 10.154

Review 6.  Language, executive function and social cognition in the diagnosis of frontotemporal dementia syndromes.

Authors:  Michał Harciarek; Stephanie Cosentino
Journal:  Int Rev Psychiatry       Date:  2013-04

Review 7.  Clinical diagnostic criteria and classification controversies in frontotemporal lobar degeneration.

Authors:  Katya Rascovsky; Murray Grossman
Journal:  Int Rev Psychiatry       Date:  2013-04

Review 8.  Diagnosis and treatment of dementia: 2. Diagnosis.

Authors:  Howard H Feldman; Claudia Jacova; Alain Robillard; Angeles Garcia; Tiffany Chow; Michael Borrie; Hyman M Schipper; Mervin Blair; Andrew Kertesz; Howard Chertkow
Journal:  CMAJ       Date:  2008-03-25       Impact factor: 8.262

9.  Distinct cognitive profiles and rates of decline on the Mattis Dementia Rating Scale in autopsy-confirmed frontotemporal dementia and Alzheimer's disease.

Authors:  Katya Rascovsky; David P Salmon; Lawrence A Hansen; Douglas Galasko
Journal:  J Int Neuropsychol Soc       Date:  2008-05       Impact factor: 2.892

10.  Are we comparing frontotemporal dementia and Alzheimer disease patients with the right measures?

Authors:  Mariel B Deutsch; Li-Jung Liang; Elvira E Jimenez; Michelle J Mather; Mario F Mendez
Journal:  Int Psychogeriatr       Date:  2016-04-15       Impact factor: 3.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.